Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Genomic Health, Inc.
Lobbying Relationship
Bills mentioned
H.R.3207: Modernizing Laboratory Test Standards for Patients Act of 2011
Sponsor: Michael C. Burgess (R-Texas)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Sheila D. Walcoff | 2006-2007: Counselor to the Honorable Michael O. Leavitt (Immediate Office of the Secretary); US. Dept. Of Health and Human Serivces; 2004-2006: Assoc Commissioner for External Relations, U.S. FDA; 1998-1999: Majority Counsel, Armed Service Committee, U.S. House of Reprsentatives |
| Sheila Walcoff | 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed 2006-07: Counselor to HHS Secretary Michael O. Leavitt (Immediate Office of the Secretary), US Dept of Health & Human Service 2004-2006 Assoc Commissioner for External Relations, US FDA; 1998-99 Majority Counsel Armed Services Committee, US House Of Representatives Leavitt (Immediate Office of the Secretary), US Dept. of Health and Human Services; 2004-2006 |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate